Showing 241-250 of 7027 results for "".
Analyzing the Overlap Between Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/analyzing-the-overlap-between-atopic-dermatitis-prurigo-nodularis-and-chronic-spontaneous-urticaria/50877/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Editorial Board member Jason E. Hawkes, MD, MS, FAAD, to discuss three different immune-mediated inflammatory skin conditions and how understanding their mechanisms can inform optimal treatment, based on the InternationalThe Benefits of Balneotherapy for Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/the-benefits-of-balneotherapy-for-atopic-dermatitis/39776/Practical Dermatology editorial board member Peter Lio, MD, and Karan Lal, DO, MS, FAAD, discuss the use of balneotherapy as an adjunctive treatment for dermatologic diseases, including an International Journal of Biometeorology article titled, “Balneotherapy using thermal mineral water baths and deLong-Term Bimzelx Data Presented
https://practicaldermatology.com/series/dermwire-tv/long-term-bimzelx-data-presented/35563/In this week's DermwireTV, new long-term data is presented for Bimzelx (bimekizumab-bkzx) for two indications; an analysis examines the correlation between proximity to tanning facilities and melanoma incidence; and in our C-Suite Chats feature, we hear from the Founder and CEO of Joya Health.Analysis Evaluates Risks of Cardiovascular Events Among Biologics for Psoriatic Diseases
https://practicaldermatology.com/series/dermwire-tv/analysis-evaluates-risks-of-cardiovascular-events-among-biologics-for-psoriatic-diseases/32412/In this week's DermwireTV, a new analysis evaluates the risks of major adverse cardiovascular events among patients treated with biologics for psoriatic diseases; a phase 3 clinical trial examines the use of nemolizumab in adults with prurigo nodularis; and the president of Journey Medical discussesSDPA: Medical Director Dr. Hilary Baldwin on Conference Planning Process
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-conference-planning-process/29507/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. Dr. Baldwin shares insights on the process of planning SDPA.DermWire TV Extra: Dr. Bunick on BPO Study
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-bunick-bpo-study/29165/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the new Journal of Investigative Dermatology article he co-authored, "Evaluation of Benzene Presence and Formulation in Benzoyl Peroxide Drug Products."FDA Approves Botox for Vertical Platysma Bands
https://practicaldermatology.com/series/dermwire-tv/fda-approves-botox-vertical-platysma-bands/29127/In this week's DermwireTV, Botox is approved for its fourth aesthetic indication in the US; the FDA clears a new laser for the long-term treatment of patients with acne vulgaris; and the Chief Scientific Officer of Leo Pharma talks about treatment options for chronic hand eczema.Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uWhat are Dermatologists’ Obstacles to Buy and Bill?
https://practicaldermatology.com/conferences/maui-derm-2024/what-are-dermatologists-obstacles-to-buy-and-bill/20241/Challenges with fee schedules have prompted many dermatologists to consider the buy and bill model. In a conversation between Practical Dermatology’s Chief Medical Editor Neal Bhatia, MD and Mark Kaufmann, MD, associate clinical professor at Mount Sinai, the doctors discuss some of the opportunitiesBurnout; Qwo Campaign; Differin, Cetaphil Programs; DermTech Data: DermWireTV
https://practicaldermatology.com/topics/skin-cancer-photoprotection/burnout-qwo-campaign-differin-cetaphil-programs-dermtech-data-dermwiretv/20063/The Dr. Lorna Breen Health Care Provider Protection Act is headed to the president, as the latest Medscape Physician Burnout and Depression Report shows more than half of physicians experiencing burnout say it has a strong or severe impact on their life. Differin marks Retinoid Awareness Week. Cetap